Company / Operating Margin
ResMed Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
32.8%
FY2025
5-year range
26.8% / 32.8%
FY2021-FY2025
Trend
+16.3%
vs FY2024
Sector context
#4 of 148
Health Care
What the data says
Among 148 Health Care companies, ResMed is in the top 3% for operating margin. Operating Margin has fluctuated over the past 10 years, ranging from 20.6% in FY2017 to 32.8% in FY2025.
Based on SEC 10-K filings.
32.8% in FY2025 with a 5-year CAGR of +5.4%. Top quartile in the Health Care sector.
Improved from 26.8% to 32.8% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- +4.8pp
- 5-Year Change
- +5.4pp
- 10-Year Change
- -
Sector benchmark
Top 3% in Health CareTop 3% of 148This company 32.8% Sector average -284.5%
▼
+111.5% above sector average
Key checks
Key Insights
- In FY2025, operating margin increased 16.3% year-over-year.
- Currently 317.2pp above the Health Care sector average.
- Lowest operating margin in the period was in FY2017.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 32.8% | +16.3% |
| FY2024 | 28.2% | +5.1% |
| FY2023 | 26.8% | -4.1% |
| FY2022 | 28.0% | -1.1% |
| FY2021 | 28.3% | +3.3% |
| FY2020 | 27.4% | +23.2% |
| FY2019 | 22.2% | -4.0% |
| FY2018 | 23.2% | +12.4% |
| FY2017 | 20.6% | -11.7% |
| FY2016 | 23.3% | -4.3% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026